Literature DB >> 29936484

Correlation Between Contrast-enhanced Ultrasound Characteristics (Qualitative and Quantitative) and Pathological Prognostic Factors in Breast Cancer.

Irene Vraka1, Evangelia Panourgias1, Emmanouil Sifakis2, Andreas Koureas1, Petros Galanis3, Dionysios Dellaportas4, Athanasios Gouliamos1, Aristides Antoniou1.   

Abstract

BACKGROUND/AIM: Little is known about the correlation between contrast-enhanced ultrasound (CEUS) characteristics and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between CEUS characteristics and pathological prognostic factors. PATIENTS AND METHODS: A retrospective study with 34 malignant breast lesions was conducted. CEUS characteristics included qualitative characteristics (e.g. lesion's enhancement degree and order, internal lesion homogeneity etc.) and quantitative characteristics (e.g. peak intensity, time to peak etc.). Also, pathological prognostic factors were included (e.g. tumor grade, estrogen receptor status etc.).
RESULTS: Blurred lesion margins were observed more often in tumors of high histological grade (p=0.01) and in estrogen receptor-negative tumors (p=0.049). Furthermore, perilesional enhancement was associated with positive Ki-67 expression (p=0.049), while heterogeneous internal sentinel lymph node enhancement was associated with malignant infiltration of the node (p=0.002).
CONCLUSION: CEUS has the potential to provide a prevision of pathological prognostic factors in malignant breast lesions, helping in the better early patient management. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Breast cancer; contrast-enhanced ultrasound; prognosis; qualitative analysis; quantitative analysis

Mesh:

Substances:

Year:  2018        PMID: 29936484      PMCID: PMC6117754          DOI: 10.21873/invivo.11333

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  49 in total

1.  Modeling ultrasound contrast measurement of blood flow and perfusion in biological tissue.

Authors:  Johan M Thijssen; Chris L de Korte
Journal:  Ultrasound Med Biol       Date:  2005-02       Impact factor: 2.998

Review 2.  Epidemiology of breast cancer.

Authors:  Kristen A Ban; Constantine V Godellas
Journal:  Surg Oncol Clin N Am       Date:  2014-07       Impact factor: 3.495

3.  Intratumoral hypoxia resulting in the presence of a fibrotic focus is an independent predictor of early distant relapse in lymph node-negative breast cancer patients.

Authors:  C Colpaert; P Vermeulen; P van Beest; G Goovaerts; J Weyler; P Van Dam; L Dirix; E Van Marck
Journal:  Histopathology       Date:  2001-10       Impact factor: 5.087

4.  Estrogen receptor (ER) mRNA and ER-related gene expression in breast cancers that are 1% to 10% ER-positive by immunohistochemistry.

Authors:  Takayuki Iwamoto; Daniel Booser; Vicente Valero; James L Murray; Kimberly Koenig; Francisco J Esteva; Naoto T Ueno; Jie Zhang; Weiwei Shi; Yuan Qi; Junji Matsuoka; Elliana J Yang; Gabriel N Hortobagyi; Christos Hatzis; W Fraser Symmans; Lajos Pusztai
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

5.  Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis.

Authors:  Thomas C Putti; Dalia M Abd El-Rehim; Emad A Rakha; Claire E Paish; Andrew H S Lee; Sarah E Pinder; Ian O Ellis
Journal:  Mod Pathol       Date:  2005-01       Impact factor: 7.842

6.  Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer.

Authors:  Frédérique Penault-Llorca; Fabrice André; Christine Sagan; Magali Lacroix-Triki; Yves Denoux; Veronique Verriele; Jocelyne Jacquemier; Marie Christine Baranzelli; Frederic Bibeau; Martine Antoine; Nicole Lagarde; Anne-Laure Martin; Bernard Asselain; Henri Roché
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

Review 7.  Current issues in ER and HER2 testing by IHC in breast cancer.

Authors:  Allen M Gown
Journal:  Mod Pathol       Date:  2008-05       Impact factor: 7.842

8.  Angiogenic potential of malignant and non-malignant human breast tissues in an in vivo angiogenesis model.

Authors:  H C Lichtenbeld; A F Barendsz-Janson; H van Essen; H Struijker Boudier; A W Griffioen; H F Hillen
Journal:  Int J Cancer       Date:  1998-07-29       Impact factor: 7.396

9.  Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study.

Authors:  Yi-Xuan Zhao; Shuang Liu; Yan-Bing Hu; Yan-Yan Ge; Dong-Mei Lv
Journal:  Onco Targets Ther       Date:  2017-02-22       Impact factor: 4.147

10.  Contrast-Enhanced Ultrasonography Features of Breast Malignancies with Different Sizes: Correlation with Prognostic Factors.

Authors:  Li-Xia Zhao; Hui Liu; Qing Wei; Guang Xu; Jian Wu; Hui-Xiong Xu; Rong Wu; Huan Pu
Journal:  Biomed Res Int       Date:  2015-12-31       Impact factor: 3.411

View more
  6 in total

1.  Contrast-enhanced ultrasound: a valuable modality for extracapsular extension assessment in papillary thyroid cancer.

Authors:  Yan Zhang; Xia Zhang; Jie Li; Qian Cai; Zhi Qiao; Yu Kun Luo
Journal:  Eur Radiol       Date:  2021-01-07       Impact factor: 5.315

Review 2.  Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer.

Authors:  Ioana Boca Bene; Sorin M Dudea; Anca I Ciurea
Journal:  J Pers Med       Date:  2021-01-30

3.  Correlation of breast cancer microcirculation construction with tumor stem cells (CSCs) and epithelial-mesenchymal transition (EMT) based on contrast-enhanced ultrasound (CEUS).

Authors:  Xiaoling Leng; Guofu Huang; Siyi Li; Miaomiao Yao; Jianbing Ding; Fucheng Ma
Journal:  PLoS One       Date:  2021-12-21       Impact factor: 3.240

4.  Ultrasound and Contrast-Enhanced Ultrasound Characteristics Associated With cN1 and Microscopic pN1 in Papillary Thyroid Carcinoma.

Authors:  Wen Li; Shusheng Qiu; Ling Ren; Qiuyang Li; Shaowei Xue; Jie Li; Yan Zhang; Yukun Luo
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-24       Impact factor: 5.555

5.  Comparison of Linear and Convex-Array Transducers in Assessing the Enhancement Characteristics of Suspicious Breast Lesions at Contrast-Enhanced Ultrasound (CEUS).

Authors:  Ioana Boca Bene; Anca Ileana Ciurea; Cristiana Augusta Ciortea; Ștefan Cristian Vesa; Sorin Marian Dudea
Journal:  Diagnostics (Basel)       Date:  2022-03-24

6.  Radiomic Signatures Derived from Hybrid Contrast-Enhanced Ultrasound Images (CEUS) for the Assessment of Histological Characteristics of Breast Cancer: A Pilot Study.

Authors:  Ioana Bene; Anca Ileana Ciurea; Cristiana Augusta Ciortea; Paul Andrei Ștefan; Larisa Dorina Ciule; Roxana Adelina Lupean; Sorin Marian Dudea
Journal:  Cancers (Basel)       Date:  2022-08-12       Impact factor: 6.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.